Cargando...

Lapatinib – Member of a New Generation of ErbB-Targeting Drugs

SUMMARY: Women with advanced or metastatic ErbB2 (HER2)-positive breast cancer have limited therapeutic options once their disease has progressed on trastuzumab-based standard initial chemotherapy regimens. Therefore, there has been a clear need for alternative treatments in this advanced setting. T...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Untch, Michael, Lück, Hans-Joachim
Formato: Artigo
Idioma:Inglês
Publicado: S. Karger GmbH 2010
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2931094/
https://ncbi.nlm.nih.gov/pubmed/20847830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000285750
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!